Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 3/20 | 0.52 |
| ▸ | DRD2 | P14416 | 3/20 | 0.51 |
| ▸ | DRD4 | P21917 | 2/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8565700 | 0.89 | CHRM3 (0.56) | CHRM3DRD2DRD4SIGMAR1CHRM2 | |
| SCHEMBL8570499 | 0.89 | CHRM3 (0.55) | CHRM3DRD2DRD4DRD3SIGMAR1 | |
| SCHEMBL6166562 | 0.89 | CHRM3 (0.55) | CHRM3DRD2DRD4DRD3SIGMAR1 | |
| SCHEMBL6166416 | 0.88 | CHRM3 (0.52) | CHRM3DRD2DRD4DRD3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL6168628 | 0.87 | CHRM3 (0.52) | CHRM3DRD2DRD4DRD3SIGMAR1 | |
| SCHEMBL8567873 | 0.85 | MEN1 (0.49) | CHRM3DRD2DRD4DRD3CHRM2 | |
| SCHEMBL8570094 | 0.85 | CHRM3 (0.51) | CHRM3DRD2DRD4SIGMAR1CHRM2 | |
| SCHEMBL6168220 | 0.85 | CHRM2 (0.49) | CHRM3DRD2DRD4DRD3SIGMAR1 | |
| SCHEMBL6168606 | 0.84 | OPRL1 (0.52) | CHRM3DRD2DRD4DRD3CHRM2 | |
| SCHEMBL29445321 | 0.84 | OPRL1 (0.52) | CHRM3DRD2DRD4DRD3CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1122253-B1 | QUINAZOLINONE DERIVATIVES | SUMITOMO PHARMA (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-6645971-B1 | Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2003-11-11 | — | — | US | disclosed |
| EP-1122253-A1 | QUINAZOLINONE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-08-08 | — | — | EP | disclosed |